🚀 VC round data is live in beta, check it out!
Conmed Valuation Multiples
Discover revenue and EBITDA valuation multiples for Conmed and similar public comparables like Anbio Biotechnology, Shanghai Haohai, iRadimed, Mani Inc. and more.
Conmed Overview
About Conmed
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
Founded
1970
HQ
Employees
3.9K
Website
Financials (LTM)
EV
$2B
Conmed Financials
Conmed reported last 12-month revenue of $1B and EBITDA of $273M.
In the same LTM period, Conmed generated $778M in gross profit, $273M in EBITDA, and $140M in net income.
Revenue (LTM)
Conmed P&L
In the most recent fiscal year, Conmed reported revenue of $1B and EBITDA of $276M.
Conmed expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $778M | XXX | $750M | XXX | XXX | XXX |
| Gross Margin | 57% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | $273M | XXX | $276M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 16% | XXX | XXX | XXX |
| Net Profit | $140M | XXX | $143M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | — | — | $794M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Conmed Stock Performance
Conmed has current market cap of $1B, and enterprise value of $2B.
Market Cap Evolution
Conmed's stock price is $39.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | 0.0% | XXX | XXX | XXX | $4.75 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialConmed Valuation Multiples
Conmed trades at 1.4x EV/Revenue multiple, and 7.2x EV/EBITDA.
EV / Revenue (LTM)
Conmed Financial Valuation Multiples
As of April 19, 2026, Conmed has market cap of $1B and EV of $2B.
Equity research analysts estimate Conmed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Conmed has a P/E ratio of 8.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 7.2x | XXX | 7.1x | XXX | XXX | XXX |
| EV/EBIT | 9.3x | XXX | 9.1x | XXX | XXX | XXX |
| EV/Gross Profit | 2.5x | XXX | 2.6x | XXX | XXX | XXX |
| P/E | 8.4x | XXX | 8.2x | XXX | XXX | XXX |
| EV/FCF | 11.8x | XXX | 12.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Conmed Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Conmed Margins & Growth Rates
Conmed's revenue in the last 12 month grew by 1%.
Conmed's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Conmed's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Conmed's rule of X is 17% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Conmed Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | (1%) | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 0% | XXX | (3%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 17% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 47% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Conmed Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Conmed | XXX | XXX | XXX | XXX | XXX | XXX |
| Anbio Biotechnology | XXX | XXX | XXX | XXX | XXX | XXX |
| Shanghai Haohai | XXX | XXX | XXX | XXX | XXX | XXX |
| iRadimed | XXX | XXX | XXX | XXX | XXX | XXX |
| Mani Inc. | XXX | XXX | XXX | XXX | XXX | XXX |
| Avanos Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Conmed M&A Activity
Conmed acquired XXX companies to date.
Last acquisition by Conmed was on XXXXXXXX, XXXXX. Conmed acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Conmed
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialConmed Investment Activity
Conmed invested in XXX companies to date.
Conmed made its latest investment on XXXXXXXX, XXXXX. Conmed invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Conmed
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Conmed
| When was Conmed founded? | Conmed was founded in 1970. |
| Where is Conmed headquartered? | Conmed is headquartered in United States. |
| How many employees does Conmed have? | As of today, Conmed has over 3K employees. |
| Who is the CEO of Conmed? | Conmed's CEO is Patrick J. Beyer. |
| Is Conmed publicly listed? | Yes, Conmed is a public company listed on NYSE. |
| What is the stock symbol of Conmed? | Conmed trades under CNMD ticker. |
| When did Conmed go public? | Conmed went public in 1987. |
| Who are competitors of Conmed? | Conmed main competitors are Anbio Biotechnology, Shanghai Haohai, iRadimed, Mani Inc.. |
| What is the current market cap of Conmed? | Conmed's current market cap is $1B. |
| What is the current revenue of Conmed? | Conmed's last 12 months revenue is $1B. |
| What is the current revenue growth of Conmed? | Conmed revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Conmed? | Current revenue multiple of Conmed is 1.4x. |
| Is Conmed profitable? | Yes, Conmed is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Conmed? | Conmed's last 12 months EBITDA is $273M. |
| What is Conmed's EBITDA margin? | Conmed's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Conmed? | Current EBITDA multiple of Conmed is 7.2x. |
| What is the current FCF of Conmed? | Conmed's last 12 months FCF is $168M. |
| What is Conmed's FCF margin? | Conmed's last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of Conmed? | Current FCF multiple of Conmed is 11.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.